How The treatment Works
The Smoothbeam laser emits a beam of light that will alter the sebaceous glands underneath the skin. These are the glands that produce the oil that feeds the bacteria which causes subsequent inflammation.
This laser uses a unique diode technology to target the sebaceous gland which is the gland which produces oil. After several treatments the gland is reduced, thereby limiting oil production. Its patented 1450 nm wavelength heats the upper dermis and limits the penetration into skin to 400-500 microns where the sebaceous glands are located.
As an added benefit for patients with acne scarring seeking smoother skin, Smoothbeam safely improves acne scars and can also softens fine lines and wrinkles around the eyes.
Instead of drying out the skin, killing the germs, or drying up oil production, the Smoothbeam laser actually alters these glands.
The Smoothbeam laser is FDA-approved for the treatment of acne and acne scars. It allows for “lunchtime procedures” with no downtime since it is a non-ablative treatment.
Schedule a Consultation
Frequently Asked Questions
What kind of acne does the Smoothbeam treat?
Should I continue to use my acne creams and medications?
How does the Smoothbeam compare to blue-light devices?
How much does this procedure cost?
What will my face look like after treatment?
What precautions should I take?
Is Smoothbeam painful?
How many treatments are required?
How long will results last?
Smoothbeam Clinical Study
Clinical Study Protocol
In clinical studies, Smoothbeam exhibited a much higher clearance rate of acne lesions compared to existing therapies. There were also no unusual side effects or adverse reactions to Smoothbeam unlike drug therapy which has a well-publicized side-effect profile. Accutane, for instance, is known to cause severe birth defects and has been associated with depression. Finally, other treatments for acne cause severe drying and irritation of the skin for many patients. In addition, laser therapy is also expected to be less costly as it requires as few as 4 treatments compared to drug and topical skin creams, which a patient can be expected to use for years.
Twenty-seven patients were treated on bilateral areas of the back that were matched for acne severity at the start of the study. The areas were mapped using a template to mark the exact location for follow-ups and repeat treatments. One clinical site on the back received laser treatment with the Smoothbeam, and the other site was used as a control. There were four treatments spaced three weeks apart. Patients were followed for at least six months after their last treatment.
Clearing of acne lesions was calculated by manual counts of remaining lesions in both the treatment and control sites. Reductions in acne lesion counts were observed as soon as three weeks after the initial treatment. The clinical study demonstrated a 98% reduction of acne lesions in as few as four treatments. At the 24-week follow up, 100% lesion clearance was seen in all but one patient having 2 lesions present.